Short answer
Pennant Group, Inc. (PNTG) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $229M (up 26.8% year over year) with net income of $6M.
Q3 2025 key financials · XBRL
- Revenue
- $229M
- +26.8% YoY · +4.3% QoQ
- Net income
- $6M
- −2.0% YoY · −14.2% QoQ
- Operating margin
- 4.5%
- EPS (diluted)
- $0.17
- −10.5% YoY · −15.0% QoQ
Source: XBRL data from the Pennant Group, Inc. (PNTG) Q3 2025 10-Q on SEC EDGAR. USD.
Pennant Group, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added regulatory risk: Potential adverse impact from CMS 2026 HH PPS Proposed Rule reducing Medicare home health reimbursement
- Material regulatory update: OBBBA effects may cause material adverse Medicaid reimbursement, varying by state response and Medicaid exposure
- Impactful compliance risk: Federal government shutdown from October 1, 2025, disrupting CMS operations and creating operational uncertainty
- Operational/market risk: Commercial payors adjusting payments based on Medicare rate reductions may negatively affect revenue streams
- No new financial risks disclosed; prior risks on liquidity, debt, or currency exposure not updated this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pennant Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.